10.1016/j.jhep.2018.11.011

LAYSUMM

TITLE

Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

PARAGRAPH

A large number of patients with hepatitis C virus have been treated with glecaprevir/pibrentasvir (G/P) within the NAVIGATORE-Lombardia Network, in Italy.

This is the first real-world study evaluating effectiveness and safety of G/P in patients with hepatitis C virus treated according to international recommendations.

This study demonstrated excellent effectiveness (with sustained virological response rates of 99.3%) and safety profiles.